SlideShare a Scribd company logo
THALASSAEMIA IN BANGLADESH

Dr.
Dr Waqar Ahmed Khan MBBS M Phil
                  Khan.MBBS,M.Phil
Professor of Pathology
Bangladesh Institute of Child Health
Dhaka Shishu (Children) Hospital
President
Dhaka Shishu Hospital Thalassaemia
Dhaka,Bangladesh.
Bangladesh-D
    B
    Bangladesh-Demographic Data
        l d h          hi D t


   Area: 1,47,570 sq.km. or 57,295
    sq.miles.
   Population: 142,319,000
   Birth rate:22.9 births/1000
    population.
          l ti
   Infant mortality:45/1000 live births
   Per capita income: US$ 1700
                              1700.
   6.1% of the total national budget is
    allotted to health sector.
   Ethinic groups: Bengali 98%
   Tribal and Non –Bengali Muslims 2%
                          g
HEALTH SYSTEM
• Health services provided through public
  and private sectors
       p
• Public sector provides out patient,in
  patient and preventive care
                          care.
• Private provides out patient, and in patient
  curative care taking big share of profit
HEALTH SYSTEM
• Health,Nutrition & Population Sector
         ,               p
  Programme to reduce (2003-2011)
• 1 MMR
  1.MMR
• 2.Infant and under 5 mortality rate
• 3.Malnutrition
• 4 Tuberculosis
  4.Tuberculosis
• 5.Non-communicable diseases but not Hb
• disorders.
• Th l
  Thalassaemia i lik l t b i l d d i th
               i is likely to be included in the
  next HNPSP
EPIDEMIOLOGY
• WHO Data
• Beta trait 3%
• Hb E trait 4%

• Our Data
• Beta trait 4.1%
• Hb E trait 6.1%
EPIDEMIOLOGY

• The most common abnormal Hb seen is
  Hb E

 Hb S and Hb H occasionally seen
EPIDEMIOLOGY
• Wide carrier variation in carrier status
• In Chittagong 48 tribal children were
  screened 42% were E trait and
• Another screening programme in Bengali
 school children(110) 15% were E trait and
  10% were Beta trait
• I Gaibandha 2 B
  In G ib dh 257 Bengali women were
                             li
  screened and 22% were E trait and 10%
  were Beta trait
EPIDIEMIOLOGY
Expected total number of beta thalassaemia
 born annually -1040
              y

Expected total number of Hb E b t
E      t dt t l   b    f      beta
  thalassaemia born annually -6443
EPIDEMIOLOGY
• No data regarding the number of
              g      g
  thalassaemic patients.
• There is no patient’s registry
                patient s
• It is estimated that there about 90,000
  patients
• 85% are Hb E beta thalassaemia
                        thalassaemia.
• There is no prevention programme at any
  level.
• No regular awareness programme other
  than on International Thalassaemia Day
Carrier status in different
 divisions of Bangladesh(n-686)
Division
Di i i       No tested
             N t t d     Beta trait
                         B t t it     E t it
                                        trait    HbE di
                                                     dis   S/D t it
                                                               trait
Dhaka        252         8(3.1)       13(5.2)
Chittagong   102         3(2.9)
                         3(2 9)       3(2.9)
                                      3(2 9)     3(2.9)
                                                 3(2 9)    2(1.3)
                                                           2(1 3)
Khulna       84          2(2.4)       2(2.4)
Rajshahi     91          5(5.5)       15(16.5)
Sylhet       96          5(5.2)       4(4.2)     I(1.0)    1(1)
Barisal      62          5(8.1)       5(8.0)
Total        687         28(4.1)      42(6.1)
Hb Elect/HPLC in Dhaka Shishu
  Hospital 30/7/98-31/12/11
Hb ELECTROPHORESIS/HPLC   10928
NORMAL                    5147
BETA THAL MAJOR           461
Hb E BETA THALASSAEMIA    1657
BETA TRAIT                2048
E TRAIT                   1374
E DISEASE                 148
S/D BAND                  58
DIAGNOSTIC FACILITIES

• Cell counter widely available
• Hb Electrophoresis available in private
  hospitals and l b t i i bi cities
  h    it l    d laboratories in big iti
• HPLC in Dhaka S s u Hospital
       C        a a Shishu osp ta
  Thalassaemia Centre.
• Limited prenatal diagnostic proced re
                                procedure
  (amniotic fluid) and DNA analysis done in
  Medical University
BLOOD TRANSFUSION
•   General picture
•   Voluntary non-rumeration blood 29 4%
              non rumeration       29.4%
•   Relative blood donor           60.5%
•   Paid blood donor               10.4%

• Ref-Blood transfusion in Bangladesh
• M. D.Islam Asian J.Transfusion,2009;3(2)
•
BLOOD TRANSFUSION
• Blood Transfusion is not free of charge.

• It costs about $9.00 to purchase blood
• from blood bank centres.
• From thalassaemia centres with blood
  bank facilities the cost is less.
Blood transfusion for
       thalassaemic patients
• 60% of blood collected are utilised for
  thalassaemic patients.
                p
• Generally packed cells are used for blood
  transfusion.
  t    f i
• Certain ce t es like Bangladesh
  Ce ta centres e a g ades
  Thalassaemia Samity and Red Crescent
  Society use washed red cells
                           cells.
• Overall about 30% of patients can afford
  to keep the targeted Hb level
l
Blood Transfusion
• Patients are also admitted in hospitals and
  treated by blood transfusion in most public
           y                           p
  hospitals

• Patients in remote areas are deprived of
  even these facilities
IRON CHELATORS
• All the three chelators are available in big
  cities and imported .Government has
                p
  exempted tax on these drugs.
• The drugs are not available free of charge
DRUGS USED IN
                 BANGLADESH
CENTRE         Deferiprone
               D f i         Desferroxami D f
                             D f        i Deferasirox
                                                 i      COMBINED
                             ne
Bangladesh   66%                          34%
Thalassaemia
Samity
Thalassaemia 10%             60%          5%            25%
Welfare
Society
Bangladesh
Thalassaemia
Foundation
Dhaka Shishu 35%             15%          5%            45%
Hospital
Thalassaemia
Centre
Mutation analysis

The following results are obtained from 111 samples that
were sent to Dr Mary Petrou in the UK to observe the
type of mutations in Bangladesh.
Mutation pattern
IVS 1-5(G-C)    101        74.4%

Fr 41-42 (
   41 42 (-     5          4.5%
                           4 5%
TTCT)
Fr-8-9(+G)      4          3.65

Codon 30(G-C) 4
      30(G C)              2.7%
                           2 7%

-90(C-T)
 90(C T)        3          2.7%
                           2 7%

Codon 15(G-A) 2
        (   )              1.8%
Mutation
IVS 1-130(G-C) 2                1.8%

619bp deletion   2              1.8%
                                1 8%

Codon 30(G A) 2
      30(G-A)                   1.8%
                                1 8%

/Codon 16(-C)
         ( )     1              0.9%

Codon 15(-T)     2              0.9%

                 121
Viral infection in multi-transfused
          patients in DSHTC

No. of       HbsAg     HCV         HIV
transfused             positive    Positive
patients
92           1(1.1%)   17(18.5%)   Nil
Mymensingh Medical College and
           Hospital
No of       HbsAg             HCV                 HIV
trransfused positive          positive            positive
patients
152         13.8%             12.5%               NIL




                 Mollah et al,jn Health popul Ntr.2003
EXPERT THALASSAEMIA
CENTRES IN BANGLADESH
NAME                                        NO
DHAKA SHISHU HOSPITAL THALASSAEMIA CENTRE   3000
BANGLADESH THALASSAEMIA SAMITY DHAKA
                        SAMITY,DHAKA,       3000+
BANGLADESH THALASSAEMIA FOUNDATION,DHAKA    796
THALASSAEMIA WELFARE SOCIETY,CHITTAGONG     700
Dhaka Shishu (Children)
       Hospital
DHAKA SHISHU HOSPITAL THALASSAEMIA CENTER
Bangladesh - Current Situation in Control Strategies and Health Systems in Asia

More Related Content

What's hot

Donor Lymphocyte Infusion: Dr. Chenhua Yan
Donor Lymphocyte Infusion: Dr. Chenhua YanDonor Lymphocyte Infusion: Dr. Chenhua Yan
Donor Lymphocyte Infusion: Dr. Chenhua Yan
spa718
 
Donor Lymphocyte Infusion in Patients with Hematological Malignancies after T...
Donor Lymphocyte Infusion in Patients with Hematological Malignancies after T...Donor Lymphocyte Infusion in Patients with Hematological Malignancies after T...
Donor Lymphocyte Infusion in Patients with Hematological Malignancies after T...spa718
 
Clinical use of high-efficiency hemodialysis treatments- Long-term assessment
Clinical use of high-efficiency hemodialysis treatments- Long-term assessmentClinical use of high-efficiency hemodialysis treatments- Long-term assessment
Clinical use of high-efficiency hemodialysis treatments- Long-term assessmentViroj Barlee
 
Sri Lanka - Current Situation in Control Strategies and Health Systems in Asia
Sri Lanka - Current Situation in Control Strategies and Health Systems in AsiaSri Lanka - Current Situation in Control Strategies and Health Systems in Asia
Sri Lanka - Current Situation in Control Strategies and Health Systems in Asia
Thalassaemia International Federation
 
Liao2011 phân tích máu cuống rốn để khẳng định chẩn đoán nhanh trước sinh bện...
Liao2011 phân tích máu cuống rốn để khẳng định chẩn đoán nhanh trước sinh bện...Liao2011 phân tích máu cuống rốn để khẳng định chẩn đoán nhanh trước sinh bện...
Liao2011 phân tích máu cuống rốn để khẳng định chẩn đoán nhanh trước sinh bện...
Võ Tá Sơn
 
immunotherapy for multiple myeloma
immunotherapy for multiple myelomaimmunotherapy for multiple myeloma
immunotherapy for multiple myeloma
spa718
 
Rituximab in Nephrology (Different Uses & Available Evidence) - Dr. Gawad
Rituximab in Nephrology (Different Uses & Available Evidence) - Dr. GawadRituximab in Nephrology (Different Uses & Available Evidence) - Dr. Gawad
Rituximab in Nephrology (Different Uses & Available Evidence) - Dr. Gawad
NephroTube - Dr.Gawad
 
Advance DTT article for NCABB
Advance DTT article for NCABBAdvance DTT article for NCABB
Advance DTT article for NCABBjeloweryii
 
Dengue Hemorrhagic Fever
Dengue Hemorrhagic FeverDengue Hemorrhagic Fever
Dengue Hemorrhagic Fever
spa718
 

What's hot (10)

lancet
lancetlancet
lancet
 
Donor Lymphocyte Infusion: Dr. Chenhua Yan
Donor Lymphocyte Infusion: Dr. Chenhua YanDonor Lymphocyte Infusion: Dr. Chenhua Yan
Donor Lymphocyte Infusion: Dr. Chenhua Yan
 
Donor Lymphocyte Infusion in Patients with Hematological Malignancies after T...
Donor Lymphocyte Infusion in Patients with Hematological Malignancies after T...Donor Lymphocyte Infusion in Patients with Hematological Malignancies after T...
Donor Lymphocyte Infusion in Patients with Hematological Malignancies after T...
 
Clinical use of high-efficiency hemodialysis treatments- Long-term assessment
Clinical use of high-efficiency hemodialysis treatments- Long-term assessmentClinical use of high-efficiency hemodialysis treatments- Long-term assessment
Clinical use of high-efficiency hemodialysis treatments- Long-term assessment
 
Sri Lanka - Current Situation in Control Strategies and Health Systems in Asia
Sri Lanka - Current Situation in Control Strategies and Health Systems in AsiaSri Lanka - Current Situation in Control Strategies and Health Systems in Asia
Sri Lanka - Current Situation in Control Strategies and Health Systems in Asia
 
Liao2011 phân tích máu cuống rốn để khẳng định chẩn đoán nhanh trước sinh bện...
Liao2011 phân tích máu cuống rốn để khẳng định chẩn đoán nhanh trước sinh bện...Liao2011 phân tích máu cuống rốn để khẳng định chẩn đoán nhanh trước sinh bện...
Liao2011 phân tích máu cuống rốn để khẳng định chẩn đoán nhanh trước sinh bện...
 
immunotherapy for multiple myeloma
immunotherapy for multiple myelomaimmunotherapy for multiple myeloma
immunotherapy for multiple myeloma
 
Rituximab in Nephrology (Different Uses & Available Evidence) - Dr. Gawad
Rituximab in Nephrology (Different Uses & Available Evidence) - Dr. GawadRituximab in Nephrology (Different Uses & Available Evidence) - Dr. Gawad
Rituximab in Nephrology (Different Uses & Available Evidence) - Dr. Gawad
 
Advance DTT article for NCABB
Advance DTT article for NCABBAdvance DTT article for NCABB
Advance DTT article for NCABB
 
Dengue Hemorrhagic Fever
Dengue Hemorrhagic FeverDengue Hemorrhagic Fever
Dengue Hemorrhagic Fever
 

Similar to Bangladesh - Current Situation in Control Strategies and Health Systems in Asia

Singapore - Current Situation in Control Strategies and Health Systems in Asia
Singapore - Current Situation in Control Strategies and Health Systems in AsiaSingapore - Current Situation in Control Strategies and Health Systems in Asia
Singapore - Current Situation in Control Strategies and Health Systems in Asia
Thalassaemia International Federation
 
Bone Marrow Transplantation for Thalassemia in Lower Resource Settings
Bone Marrow Transplantation for Thalassemia in Lower Resource SettingsBone Marrow Transplantation for Thalassemia in Lower Resource Settings
Bone Marrow Transplantation for Thalassemia in Lower Resource Settings
Thalassaemia International Federation
 
Paving the Way for Prevention of Haemoglobinopathies in Egypt - Ghada El-Kamah
Paving the Way for Prevention of Haemoglobinopathies in Egypt - Ghada El-KamahPaving the Way for Prevention of Haemoglobinopathies in Egypt - Ghada El-Kamah
Paving the Way for Prevention of Haemoglobinopathies in Egypt - Ghada El-Kamah
Human Variome Project
 
SS 2017: Treatment Updated on Hepatitis B or C co-infection
SS 2017: Treatment Updated on Hepatitis B or C co-infectionSS 2017: Treatment Updated on Hepatitis B or C co-infection
SS 2017: Treatment Updated on Hepatitis B or C co-infection
Sri Lanka College of Sexual Health and HIV Medicine
 
Spectrum of Thal.pptx
Spectrum of Thal.pptxSpectrum of Thal.pptx
Spectrum of Thal.pptx
biplabendu talukdar
 
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
UC San Diego AntiViral Research Center
 
NVHCP.pptx
 NVHCP.pptx NVHCP.pptx
NVHCP.pptx
Vikrant569983
 
Hong Kong - Current Situation in Control Strategies and Health Systems in Asia
Hong Kong - Current Situation in Control Strategies and Health Systems in AsiaHong Kong - Current Situation in Control Strategies and Health Systems in Asia
Hong Kong - Current Situation in Control Strategies and Health Systems in Asia
Thalassaemia International Federation
 
High Prevalence of Diabetes Mellitus among Adult Patients with Viral Hepatiti...
High Prevalence of Diabetes Mellitus among Adult Patients with Viral Hepatiti...High Prevalence of Diabetes Mellitus among Adult Patients with Viral Hepatiti...
High Prevalence of Diabetes Mellitus among Adult Patients with Viral Hepatiti...
SSR Institute of International Journal of Life Sciences
 
India - Current Situation in Control Strategies and Health Systems in Asia
India - Current Situation in Control Strategies and Health Systems in AsiaIndia - Current Situation in Control Strategies and Health Systems in Asia
India - Current Situation in Control Strategies and Health Systems in Asia
Thalassaemia International Federation
 
Clinical transfusion appropriateness audit Moyo Hospital Jokene et al 2021.pptx
Clinical transfusion appropriateness audit Moyo Hospital Jokene et al 2021.pptxClinical transfusion appropriateness audit Moyo Hospital Jokene et al 2021.pptx
Clinical transfusion appropriateness audit Moyo Hospital Jokene et al 2021.pptx
Jokene Andrew
 
A03510105
A03510105A03510105
thalassemia
thalassemiathalassemia
thalassemia
spa718
 
Thalassemia and Stem cell transplant
Thalassemia and Stem cell transplantThalassemia and Stem cell transplant
Thalassemia and Stem cell transplant
spa718
 
Blood transfusion
Blood transfusionBlood transfusion
Blood transfusion
Nursing Hi Nursing
 
HIV and Hepatitis C by Dr Alison Ratcliff
HIV and Hepatitis C by Dr Alison RatcliffHIV and Hepatitis C by Dr Alison Ratcliff
HIV and Hepatitis C by Dr Alison Ratcliff
CICM 2019 Annual Scientific Meeting
 
Anti-HLA Antibodies and Outcomes after Cord Blood Transplantation
Anti-HLA Antibodies and Outcomes after Cord Blood TransplantationAnti-HLA Antibodies and Outcomes after Cord Blood Transplantation
Anti-HLA Antibodies and Outcomes after Cord Blood Transplantationcordbloodsymposium
 
Research nursing risk factors of renal failure.pptx
Research nursing   risk factors of renal failure.pptxResearch nursing   risk factors of renal failure.pptx
Research nursing risk factors of renal failure.pptx
ssuser47b89a
 
Pd update nephro sudan 2017
Pd update nephro sudan  2017Pd update nephro sudan  2017
Pd update nephro sudan 2017
FarragBahbah
 
Understanding Chronic Graft-vs.-Host Disease
Understanding Chronic Graft-vs.-Host DiseaseUnderstanding Chronic Graft-vs.-Host Disease
Understanding Chronic Graft-vs.-Host Disease
MichaelBuckley295057
 

Similar to Bangladesh - Current Situation in Control Strategies and Health Systems in Asia (20)

Singapore - Current Situation in Control Strategies and Health Systems in Asia
Singapore - Current Situation in Control Strategies and Health Systems in AsiaSingapore - Current Situation in Control Strategies and Health Systems in Asia
Singapore - Current Situation in Control Strategies and Health Systems in Asia
 
Bone Marrow Transplantation for Thalassemia in Lower Resource Settings
Bone Marrow Transplantation for Thalassemia in Lower Resource SettingsBone Marrow Transplantation for Thalassemia in Lower Resource Settings
Bone Marrow Transplantation for Thalassemia in Lower Resource Settings
 
Paving the Way for Prevention of Haemoglobinopathies in Egypt - Ghada El-Kamah
Paving the Way for Prevention of Haemoglobinopathies in Egypt - Ghada El-KamahPaving the Way for Prevention of Haemoglobinopathies in Egypt - Ghada El-Kamah
Paving the Way for Prevention of Haemoglobinopathies in Egypt - Ghada El-Kamah
 
SS 2017: Treatment Updated on Hepatitis B or C co-infection
SS 2017: Treatment Updated on Hepatitis B or C co-infectionSS 2017: Treatment Updated on Hepatitis B or C co-infection
SS 2017: Treatment Updated on Hepatitis B or C co-infection
 
Spectrum of Thal.pptx
Spectrum of Thal.pptxSpectrum of Thal.pptx
Spectrum of Thal.pptx
 
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
 
NVHCP.pptx
 NVHCP.pptx NVHCP.pptx
NVHCP.pptx
 
Hong Kong - Current Situation in Control Strategies and Health Systems in Asia
Hong Kong - Current Situation in Control Strategies and Health Systems in AsiaHong Kong - Current Situation in Control Strategies and Health Systems in Asia
Hong Kong - Current Situation in Control Strategies and Health Systems in Asia
 
High Prevalence of Diabetes Mellitus among Adult Patients with Viral Hepatiti...
High Prevalence of Diabetes Mellitus among Adult Patients with Viral Hepatiti...High Prevalence of Diabetes Mellitus among Adult Patients with Viral Hepatiti...
High Prevalence of Diabetes Mellitus among Adult Patients with Viral Hepatiti...
 
India - Current Situation in Control Strategies and Health Systems in Asia
India - Current Situation in Control Strategies and Health Systems in AsiaIndia - Current Situation in Control Strategies and Health Systems in Asia
India - Current Situation in Control Strategies and Health Systems in Asia
 
Clinical transfusion appropriateness audit Moyo Hospital Jokene et al 2021.pptx
Clinical transfusion appropriateness audit Moyo Hospital Jokene et al 2021.pptxClinical transfusion appropriateness audit Moyo Hospital Jokene et al 2021.pptx
Clinical transfusion appropriateness audit Moyo Hospital Jokene et al 2021.pptx
 
A03510105
A03510105A03510105
A03510105
 
thalassemia
thalassemiathalassemia
thalassemia
 
Thalassemia and Stem cell transplant
Thalassemia and Stem cell transplantThalassemia and Stem cell transplant
Thalassemia and Stem cell transplant
 
Blood transfusion
Blood transfusionBlood transfusion
Blood transfusion
 
HIV and Hepatitis C by Dr Alison Ratcliff
HIV and Hepatitis C by Dr Alison RatcliffHIV and Hepatitis C by Dr Alison Ratcliff
HIV and Hepatitis C by Dr Alison Ratcliff
 
Anti-HLA Antibodies and Outcomes after Cord Blood Transplantation
Anti-HLA Antibodies and Outcomes after Cord Blood TransplantationAnti-HLA Antibodies and Outcomes after Cord Blood Transplantation
Anti-HLA Antibodies and Outcomes after Cord Blood Transplantation
 
Research nursing risk factors of renal failure.pptx
Research nursing   risk factors of renal failure.pptxResearch nursing   risk factors of renal failure.pptx
Research nursing risk factors of renal failure.pptx
 
Pd update nephro sudan 2017
Pd update nephro sudan  2017Pd update nephro sudan  2017
Pd update nephro sudan 2017
 
Understanding Chronic Graft-vs.-Host Disease
Understanding Chronic Graft-vs.-Host DiseaseUnderstanding Chronic Graft-vs.-Host Disease
Understanding Chronic Graft-vs.-Host Disease
 

More from Thalassaemia International Federation

New advances and future outlook in the management and cure of hemoglobin diso...
New advances and future outlook in the management and cure of hemoglobin diso...New advances and future outlook in the management and cure of hemoglobin diso...
New advances and future outlook in the management and cure of hemoglobin diso...
Thalassaemia International Federation
 
MRI-based Monitoring Tools for Iron Chelation
MRI-based Monitoring Tools for Iron ChelationMRI-based Monitoring Tools for Iron Chelation
MRI-based Monitoring Tools for Iron Chelation
Thalassaemia International Federation
 
MRI-based Iron Assessment for Developing Countries
MRI-based Iron Assessment for Developing CountriesMRI-based Iron Assessment for Developing Countries
MRI-based Iron Assessment for Developing Countries
Thalassaemia International Federation
 
Importance of drug quality impact on clinical outcomes around the world
Importance of drug quality impact on clinical outcomes around the worldImportance of drug quality impact on clinical outcomes around the world
Importance of drug quality impact on clinical outcomes around the world
Thalassaemia International Federation
 
Understanding molecular mechanisms leading to reactivation derepression of ga...
Understanding molecular mechanisms leading to reactivation derepression of ga...Understanding molecular mechanisms leading to reactivation derepression of ga...
Understanding molecular mechanisms leading to reactivation derepression of ga...
Thalassaemia International Federation
 
Hemoglobin F Enhancers
Hemoglobin F EnhancersHemoglobin F Enhancers
Gene Therapy of Human beta-Thalassemias
Gene Therapy of Human beta-ThalassemiasGene Therapy of Human beta-Thalassemias
Gene Therapy of Human beta-Thalassemias
Thalassaemia International Federation
 
Multi-disciplinary Care in Thalassaemia
Multi-disciplinary Care in ThalassaemiaMulti-disciplinary Care in Thalassaemia
Multi-disciplinary Care in Thalassaemia
Thalassaemia International Federation
 
The Treatment of Sickle Cell Disease
The Treatment of Sickle Cell DiseaseThe Treatment of Sickle Cell Disease
The Treatment of Sickle Cell Disease
Thalassaemia International Federation
 
Non transfusion dependent thalassemias beta-thalassemia intermedia and hb e b...
Non transfusion dependent thalassemias beta-thalassemia intermedia and hb e b...Non transfusion dependent thalassemias beta-thalassemia intermedia and hb e b...
Non transfusion dependent thalassemias beta-thalassemia intermedia and hb e b...
Thalassaemia International Federation
 
Treatment of Patients with beta‐Thalassaemias
Treatment of Patients with beta‐ThalassaemiasTreatment of Patients with beta‐Thalassaemias
Treatment of Patients with beta‐Thalassaemias
Thalassaemia International Federation
 
Taiwan - Genetic Screening and Prenatal Diagnosis of Thalassemias
Taiwan - Genetic Screening and Prenatal Diagnosis of ThalassemiasTaiwan - Genetic Screening and Prenatal Diagnosis of Thalassemias
Taiwan - Genetic Screening and Prenatal Diagnosis of Thalassemias
Thalassaemia International Federation
 
Taiwan - Current Situation in Control Strategies and Health Systems in Asia
Taiwan - Current Situation in Control Strategies and Health Systems in AsiaTaiwan - Current Situation in Control Strategies and Health Systems in Asia
Taiwan - Current Situation in Control Strategies and Health Systems in Asia
Thalassaemia International Federation
 
Australia - Current Situation in Control Strategies and Health Systems in Asia
Australia - Current Situation in Control Strategies and Health Systems in AsiaAustralia - Current Situation in Control Strategies and Health Systems in Asia
Australia - Current Situation in Control Strategies and Health Systems in Asia
Thalassaemia International Federation
 
Cambodia - Current Situation in Control Strategies and Health Systems in Asia
Cambodia - Current Situation in Control Strategies and Health Systems in AsiaCambodia - Current Situation in Control Strategies and Health Systems in Asia
Cambodia - Current Situation in Control Strategies and Health Systems in Asia
Thalassaemia International Federation
 
Viet Nam - Current Situation in Control Strategies and Health Systems in Asia
Viet Nam - Current Situation in Control Strategies and Health Systems in AsiaViet Nam - Current Situation in Control Strategies and Health Systems in Asia
Viet Nam - Current Situation in Control Strategies and Health Systems in Asia
Thalassaemia International Federation
 
Philippines - Current Situation in Control Strategies and Health Systems in Asia
Philippines - Current Situation in Control Strategies and Health Systems in AsiaPhilippines - Current Situation in Control Strategies and Health Systems in Asia
Philippines - Current Situation in Control Strategies and Health Systems in Asia
Thalassaemia International Federation
 
Malaysia - Current Situation in Control Strategies and Health Systems in Asia
Malaysia - Current Situation in Control Strategies and Health Systems in AsiaMalaysia - Current Situation in Control Strategies and Health Systems in Asia
Malaysia - Current Situation in Control Strategies and Health Systems in Asia
Thalassaemia International Federation
 
Republic of Laos - Current Situation in Control Strategies and Health Systems...
Republic of Laos - Current Situation in Control Strategies and Health Systems...Republic of Laos - Current Situation in Control Strategies and Health Systems...
Republic of Laos - Current Situation in Control Strategies and Health Systems...
Thalassaemia International Federation
 
Myanmar - Current Situation in Control Strategies and Health Systems in Asia
Myanmar - Current Situation in Control Strategies and Health Systems in AsiaMyanmar - Current Situation in Control Strategies and Health Systems in Asia
Myanmar - Current Situation in Control Strategies and Health Systems in Asia
Thalassaemia International Federation
 

More from Thalassaemia International Federation (20)

New advances and future outlook in the management and cure of hemoglobin diso...
New advances and future outlook in the management and cure of hemoglobin diso...New advances and future outlook in the management and cure of hemoglobin diso...
New advances and future outlook in the management and cure of hemoglobin diso...
 
MRI-based Monitoring Tools for Iron Chelation
MRI-based Monitoring Tools for Iron ChelationMRI-based Monitoring Tools for Iron Chelation
MRI-based Monitoring Tools for Iron Chelation
 
MRI-based Iron Assessment for Developing Countries
MRI-based Iron Assessment for Developing CountriesMRI-based Iron Assessment for Developing Countries
MRI-based Iron Assessment for Developing Countries
 
Importance of drug quality impact on clinical outcomes around the world
Importance of drug quality impact on clinical outcomes around the worldImportance of drug quality impact on clinical outcomes around the world
Importance of drug quality impact on clinical outcomes around the world
 
Understanding molecular mechanisms leading to reactivation derepression of ga...
Understanding molecular mechanisms leading to reactivation derepression of ga...Understanding molecular mechanisms leading to reactivation derepression of ga...
Understanding molecular mechanisms leading to reactivation derepression of ga...
 
Hemoglobin F Enhancers
Hemoglobin F EnhancersHemoglobin F Enhancers
Hemoglobin F Enhancers
 
Gene Therapy of Human beta-Thalassemias
Gene Therapy of Human beta-ThalassemiasGene Therapy of Human beta-Thalassemias
Gene Therapy of Human beta-Thalassemias
 
Multi-disciplinary Care in Thalassaemia
Multi-disciplinary Care in ThalassaemiaMulti-disciplinary Care in Thalassaemia
Multi-disciplinary Care in Thalassaemia
 
The Treatment of Sickle Cell Disease
The Treatment of Sickle Cell DiseaseThe Treatment of Sickle Cell Disease
The Treatment of Sickle Cell Disease
 
Non transfusion dependent thalassemias beta-thalassemia intermedia and hb e b...
Non transfusion dependent thalassemias beta-thalassemia intermedia and hb e b...Non transfusion dependent thalassemias beta-thalassemia intermedia and hb e b...
Non transfusion dependent thalassemias beta-thalassemia intermedia and hb e b...
 
Treatment of Patients with beta‐Thalassaemias
Treatment of Patients with beta‐ThalassaemiasTreatment of Patients with beta‐Thalassaemias
Treatment of Patients with beta‐Thalassaemias
 
Taiwan - Genetic Screening and Prenatal Diagnosis of Thalassemias
Taiwan - Genetic Screening and Prenatal Diagnosis of ThalassemiasTaiwan - Genetic Screening and Prenatal Diagnosis of Thalassemias
Taiwan - Genetic Screening and Prenatal Diagnosis of Thalassemias
 
Taiwan - Current Situation in Control Strategies and Health Systems in Asia
Taiwan - Current Situation in Control Strategies and Health Systems in AsiaTaiwan - Current Situation in Control Strategies and Health Systems in Asia
Taiwan - Current Situation in Control Strategies and Health Systems in Asia
 
Australia - Current Situation in Control Strategies and Health Systems in Asia
Australia - Current Situation in Control Strategies and Health Systems in AsiaAustralia - Current Situation in Control Strategies and Health Systems in Asia
Australia - Current Situation in Control Strategies and Health Systems in Asia
 
Cambodia - Current Situation in Control Strategies and Health Systems in Asia
Cambodia - Current Situation in Control Strategies and Health Systems in AsiaCambodia - Current Situation in Control Strategies and Health Systems in Asia
Cambodia - Current Situation in Control Strategies and Health Systems in Asia
 
Viet Nam - Current Situation in Control Strategies and Health Systems in Asia
Viet Nam - Current Situation in Control Strategies and Health Systems in AsiaViet Nam - Current Situation in Control Strategies and Health Systems in Asia
Viet Nam - Current Situation in Control Strategies and Health Systems in Asia
 
Philippines - Current Situation in Control Strategies and Health Systems in Asia
Philippines - Current Situation in Control Strategies and Health Systems in AsiaPhilippines - Current Situation in Control Strategies and Health Systems in Asia
Philippines - Current Situation in Control Strategies and Health Systems in Asia
 
Malaysia - Current Situation in Control Strategies and Health Systems in Asia
Malaysia - Current Situation in Control Strategies and Health Systems in AsiaMalaysia - Current Situation in Control Strategies and Health Systems in Asia
Malaysia - Current Situation in Control Strategies and Health Systems in Asia
 
Republic of Laos - Current Situation in Control Strategies and Health Systems...
Republic of Laos - Current Situation in Control Strategies and Health Systems...Republic of Laos - Current Situation in Control Strategies and Health Systems...
Republic of Laos - Current Situation in Control Strategies and Health Systems...
 
Myanmar - Current Situation in Control Strategies and Health Systems in Asia
Myanmar - Current Situation in Control Strategies and Health Systems in AsiaMyanmar - Current Situation in Control Strategies and Health Systems in Asia
Myanmar - Current Situation in Control Strategies and Health Systems in Asia
 

Recently uploaded

NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}
NEHA GUPTA
 
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptxEffective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptx
SwisschemDerma
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Top-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptxTop-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptx
SwisschemDerma
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
Sai Sailesh Kumar Goothy
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
SwastikAyurveda
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 

Recently uploaded (20)

NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}
 
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptxEffective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptx
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Top-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptxTop-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptx
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 

Bangladesh - Current Situation in Control Strategies and Health Systems in Asia

  • 1. THALASSAEMIA IN BANGLADESH Dr. Dr Waqar Ahmed Khan MBBS M Phil Khan.MBBS,M.Phil Professor of Pathology Bangladesh Institute of Child Health Dhaka Shishu (Children) Hospital President Dhaka Shishu Hospital Thalassaemia Dhaka,Bangladesh.
  • 2. Bangladesh-D B Bangladesh-Demographic Data l d h hi D t  Area: 1,47,570 sq.km. or 57,295 sq.miles.  Population: 142,319,000  Birth rate:22.9 births/1000 population. l ti  Infant mortality:45/1000 live births  Per capita income: US$ 1700 1700.  6.1% of the total national budget is allotted to health sector.  Ethinic groups: Bengali 98%  Tribal and Non –Bengali Muslims 2% g
  • 3. HEALTH SYSTEM • Health services provided through public and private sectors p • Public sector provides out patient,in patient and preventive care care. • Private provides out patient, and in patient curative care taking big share of profit
  • 4. HEALTH SYSTEM • Health,Nutrition & Population Sector , p Programme to reduce (2003-2011) • 1 MMR 1.MMR • 2.Infant and under 5 mortality rate • 3.Malnutrition • 4 Tuberculosis 4.Tuberculosis • 5.Non-communicable diseases but not Hb • disorders. • Th l Thalassaemia i lik l t b i l d d i th i is likely to be included in the next HNPSP
  • 5. EPIDEMIOLOGY • WHO Data • Beta trait 3% • Hb E trait 4% • Our Data • Beta trait 4.1% • Hb E trait 6.1%
  • 6. EPIDEMIOLOGY • The most common abnormal Hb seen is Hb E Hb S and Hb H occasionally seen
  • 7. EPIDEMIOLOGY • Wide carrier variation in carrier status • In Chittagong 48 tribal children were screened 42% were E trait and • Another screening programme in Bengali school children(110) 15% were E trait and 10% were Beta trait • I Gaibandha 2 B In G ib dh 257 Bengali women were li screened and 22% were E trait and 10% were Beta trait
  • 8. EPIDIEMIOLOGY Expected total number of beta thalassaemia born annually -1040 y Expected total number of Hb E b t E t dt t l b f beta thalassaemia born annually -6443
  • 9. EPIDEMIOLOGY • No data regarding the number of g g thalassaemic patients. • There is no patient’s registry patient s • It is estimated that there about 90,000 patients • 85% are Hb E beta thalassaemia thalassaemia. • There is no prevention programme at any level. • No regular awareness programme other than on International Thalassaemia Day
  • 10. Carrier status in different divisions of Bangladesh(n-686) Division Di i i No tested N t t d Beta trait B t t it E t it trait HbE di dis S/D t it trait Dhaka 252 8(3.1) 13(5.2) Chittagong 102 3(2.9) 3(2 9) 3(2.9) 3(2 9) 3(2.9) 3(2 9) 2(1.3) 2(1 3) Khulna 84 2(2.4) 2(2.4) Rajshahi 91 5(5.5) 15(16.5) Sylhet 96 5(5.2) 4(4.2) I(1.0) 1(1) Barisal 62 5(8.1) 5(8.0) Total 687 28(4.1) 42(6.1)
  • 11. Hb Elect/HPLC in Dhaka Shishu Hospital 30/7/98-31/12/11 Hb ELECTROPHORESIS/HPLC 10928 NORMAL 5147 BETA THAL MAJOR 461 Hb E BETA THALASSAEMIA 1657 BETA TRAIT 2048 E TRAIT 1374 E DISEASE 148 S/D BAND 58
  • 12. DIAGNOSTIC FACILITIES • Cell counter widely available • Hb Electrophoresis available in private hospitals and l b t i i bi cities h it l d laboratories in big iti • HPLC in Dhaka S s u Hospital C a a Shishu osp ta Thalassaemia Centre. • Limited prenatal diagnostic proced re procedure (amniotic fluid) and DNA analysis done in Medical University
  • 13. BLOOD TRANSFUSION • General picture • Voluntary non-rumeration blood 29 4% non rumeration 29.4% • Relative blood donor 60.5% • Paid blood donor 10.4% • Ref-Blood transfusion in Bangladesh • M. D.Islam Asian J.Transfusion,2009;3(2) •
  • 14. BLOOD TRANSFUSION • Blood Transfusion is not free of charge. • It costs about $9.00 to purchase blood • from blood bank centres. • From thalassaemia centres with blood bank facilities the cost is less.
  • 15. Blood transfusion for thalassaemic patients • 60% of blood collected are utilised for thalassaemic patients. p • Generally packed cells are used for blood transfusion. t f i • Certain ce t es like Bangladesh Ce ta centres e a g ades Thalassaemia Samity and Red Crescent Society use washed red cells cells. • Overall about 30% of patients can afford to keep the targeted Hb level l
  • 16. Blood Transfusion • Patients are also admitted in hospitals and treated by blood transfusion in most public y p hospitals • Patients in remote areas are deprived of even these facilities
  • 17. IRON CHELATORS • All the three chelators are available in big cities and imported .Government has p exempted tax on these drugs. • The drugs are not available free of charge
  • 18. DRUGS USED IN BANGLADESH CENTRE Deferiprone D f i Desferroxami D f D f i Deferasirox i COMBINED ne Bangladesh 66% 34% Thalassaemia Samity Thalassaemia 10% 60% 5% 25% Welfare Society Bangladesh Thalassaemia Foundation Dhaka Shishu 35% 15% 5% 45% Hospital Thalassaemia Centre
  • 19. Mutation analysis The following results are obtained from 111 samples that were sent to Dr Mary Petrou in the UK to observe the type of mutations in Bangladesh.
  • 20. Mutation pattern IVS 1-5(G-C) 101 74.4% Fr 41-42 ( 41 42 (- 5 4.5% 4 5% TTCT) Fr-8-9(+G) 4 3.65 Codon 30(G-C) 4 30(G C) 2.7% 2 7% -90(C-T) 90(C T) 3 2.7% 2 7% Codon 15(G-A) 2 ( ) 1.8%
  • 21. Mutation IVS 1-130(G-C) 2 1.8% 619bp deletion 2 1.8% 1 8% Codon 30(G A) 2 30(G-A) 1.8% 1 8% /Codon 16(-C) ( ) 1 0.9% Codon 15(-T) 2 0.9% 121
  • 22. Viral infection in multi-transfused patients in DSHTC No. of HbsAg HCV HIV transfused positive Positive patients 92 1(1.1%) 17(18.5%) Nil
  • 23. Mymensingh Medical College and Hospital No of HbsAg HCV HIV trransfused positive positive positive patients 152 13.8% 12.5% NIL Mollah et al,jn Health popul Ntr.2003
  • 24. EXPERT THALASSAEMIA CENTRES IN BANGLADESH NAME NO DHAKA SHISHU HOSPITAL THALASSAEMIA CENTRE 3000 BANGLADESH THALASSAEMIA SAMITY DHAKA SAMITY,DHAKA, 3000+ BANGLADESH THALASSAEMIA FOUNDATION,DHAKA 796 THALASSAEMIA WELFARE SOCIETY,CHITTAGONG 700
  • 26. DHAKA SHISHU HOSPITAL THALASSAEMIA CENTER